Patna: Bharat Biotech has started paediatric trials of its COVID-19 vaccine Covaxin at the All India Institute of Medical Sciences (AIIMS) Patna.
The Drugs Controller General of India last month approved clinical trials of Covaxin among children and teenagers aged 2 to 18 years.
Trials on children will be carried out on 525 subjects at various sites, including AIIMS Delhi.
“The vaccine is developed using Whole-Virion Inactivated Vero Cell derived platform technology. Inactivated vaccines do not replicate and are therefore unlikely to revert and cause pathological effects. They contain dead virus, incapable of infecting people but still able to instruct the immune system to mount a defensive reaction against an infection,” stated Bharat Biotech, which has developed Covaxin indigenously in collaboration with ICMR.
Covaxin is among three COVID vaccines being used in India’s inoculation drive, Covishield and Russian Sputnik V being the others.
Sundargarh: Police arrested a man for allegedly killing his brother-in-law for torturing his sister in…
Mumbai: This is what you call a heavyweight collaboration. In a first-of-its-kind collaboration between rival…
Mohammad Aatif Ammad Kanth Anantnag (Jammu & Kashmir): On a chilly winter morning, Irshad Bhat…
Bhubaneswar: The former MLA of BJD from Chitrakonda in Odisha's Malkangiri district, Dambaru Sisa, on…
Bhubaneswar: The Jharkhand Mukti Morcha (JMM) has announced Anjani Soren as its candidate for Lok…
Bhubaneswar: India Energy Storage Alliance (IESA) signed a Memorandum of Understanding with Bhubaneswar City Knowledge…
Bhubaneswar: Odisha Vigilance on Thursday apprehended an officer in the collectorate of Nuapada district while…
Bhubaneswar: Odisha’s star javelin thrower Kishore Jena had a stellar season in 2023. And he’s…